Loading clinical trials...
Loading clinical trials...
Based on a Randomized, Double-blind, Controlled Trial, Evaluate the Effects of Probiotics on Inflammation and Metabolism in Patients With Type 2 Diabetes Mellitus.
Conditions
Interventions
Probiotics
Locations
1
China
Nanchong Central Hospital
Nanchong, Sichuan, China
Start Date
June 15, 2024
Primary Completion Date
September 15, 2024
Completion Date
December 15, 2024
Last Updated
June 3, 2024
NCT07051005
NCT07296484
NCT06671587
NCT06688461
NCT06579404
NCT07053319
Lead Sponsor
Wecare Probiotics Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions